tradingkey.logo

Butterfly Network Inc

BFLY
3.380USD
+0.145+4.49%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
853.57MMarktkapitalisierung
VerlustKGV TTM

Butterfly Network Inc

3.380
+0.145+4.49%

mehr Informationen über Butterfly Network Inc Unternehmen

Butterfly Network, Inc. is a healthcare company focused on medical imaging with its Ultrasound-on-Chip semiconductor technology and ultrasound software solutions. The Company's solution, leveraging its Ultrasound-on-Chip technology, enables the practical application of ultrasound information into the clinical workflow. Its product portfolio includes a combination of hardware and software, including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet devices, software subscriptions, and professional services. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials as well as its ScanLab education-only app, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Its devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, and Australia.

Butterfly Network Inc Informationen

BörsenkürzelBFLY
Name des UnternehmensButterfly Network Inc
IPO-datumMay 26, 2020
CEODevivo (Joseph M)
Anzahl der mitarbeiter190
WertpapierartOrdinary Share
GeschäftsjahresendeMay 26
Addresse1600 District Avenue
StadtBURLINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl01803
Telefon17815574800
Websitehttps://www.butterflynetwork.com/
BörsenkürzelBFLY
IPO-datumMay 26, 2020
CEODevivo (Joseph M)

Führungskräfte von Butterfly Network Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
4.73M
-2539052.00%
Mr. Victor Ku
Mr. Victor Ku
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
811.96K
-35968.00%
Mr. Megan Carlson
Mr. Megan Carlson
Senior Vice President - Finance & Accounting, Chief Accounting Officer
Senior Vice President - Finance & Accounting, Chief Accounting Officer
547.44K
-13803.00%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
410.00K
-142590.00%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
--
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
107.61K
-112009.00%
Ms. S. Louise Phanstiel, CPA
Ms. S. Louise Phanstiel, CPA
Independent Director
Independent Director
--
--
Dr. Elazer Edelman, M.D., Ph.D.
Dr. Elazer Edelman, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Erica G. Schwartz, M.D., J.D.
Dr. Erica G. Schwartz, M.D., J.D.
Independent Director
Independent Director
--
--
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
4.73M
-2539052.00%
Mr. Victor Ku
Mr. Victor Ku
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
811.96K
-35968.00%
Mr. Megan Carlson
Mr. Megan Carlson
Senior Vice President - Finance & Accounting, Chief Accounting Officer
Senior Vice President - Finance & Accounting, Chief Accounting Officer
547.44K
-13803.00%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
410.00K
-142590.00%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
--
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
107.61K
-112009.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Hardware
14.56M
67.74%
Software and other services
6.93M
32.26%
Nach RegionUSD
Name
Umsatz
Anteil
United States
16.09M
74.88%
International
5.40M
25.12%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Hardware
14.56M
67.74%
Software and other services
6.93M
32.26%

Aktionärsstatistik

Aktualisiert: Sun, Dec 14
Aktualisiert: Sun, Dec 14
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Glenview Capital Management, LLC
5.64%
BlackRock Institutional Trust Company, N.A.
5.60%
The Vanguard Group, Inc.
5.00%
Fosun International Ltd
4.74%
ARK Investment Management LLC
2.72%
Andere
76.30%
Aktionäre
Aktionäre
Anteil
Glenview Capital Management, LLC
5.64%
BlackRock Institutional Trust Company, N.A.
5.60%
The Vanguard Group, Inc.
5.00%
Fosun International Ltd
4.74%
ARK Investment Management LLC
2.72%
Andere
76.30%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
21.48%
Investment Advisor/Hedge Fund
8.83%
Hedge Fund
8.27%
Individual Investor
5.80%
Holding Company
4.74%
Corporation
2.01%
Research Firm
1.58%
Foundation
0.45%
Bank and Trust
0.17%
Andere
46.68%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
428
92.44M
53.05%
+2.59M
2025Q3
451
89.85M
53.29%
-19.33M
2025Q2
454
109.04M
45.47%
+15.44M
2025Q1
448
93.30M
32.79%
+20.89M
2024Q4
427
63.44M
33.09%
+12.99M
2024Q3
421
50.22M
36.44%
-5.82M
2024Q2
422
54.05M
40.04%
-11.20M
2024Q1
427
65.27M
42.32%
-12.69M
2023Q4
428
67.90M
45.33%
-4.35M
2023Q3
439
72.11M
49.91%
-4.52M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Glenview Capital Management, LLC
12.76M
5.64%
+2.80M
+28.13%
Nov 21, 2025
BlackRock Institutional Trust Company, N.A.
12.66M
5.6%
-61.48K
-0.48%
Sep 30, 2025
The Vanguard Group, Inc.
11.04M
4.88%
+483.76K
+4.58%
Sep 30, 2025
Fosun International Ltd
10.72M
4.74%
--
--
Sep 30, 2025
ARK Investment Management LLC
6.15M
2.72%
-270.89K
-4.22%
Sep 30, 2025
State Street Investment Management (US)
5.96M
2.63%
+831.40K
+16.22%
Sep 30, 2025
Hood River Capital Management LLC
5.41M
2.39%
+278.74K
+5.44%
Sep 30, 2025
Rothberg (Jonathan M)
4.73M
2.09%
-2.54M
-34.93%
Dec 16, 2025
Geode Capital Management, L.L.C.
4.60M
2.04%
+264.51K
+6.10%
Sep 30, 2025
Longview Investors LLC
4.55M
2.01%
--
--
Nov 21, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
ARK Genomic Revolution ETF
1.52%
State Street SPDR S&P Health Care Equipment ETF
1.32%
Global X HealthTech ETF
0.51%
State Street SPDR S&P Kensho New Econ Comp ETF
0.18%
iShares Micro-Cap ETF
0.1%
iShares U.S. Medical Devices ETF
0.07%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares US Small-Cap Equity Factor ETF
0.02%
Mehr Anzeigen
ARK Genomic Revolution ETF
Anteil1.52%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.32%
Global X HealthTech ETF
Anteil0.51%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.18%
iShares Micro-Cap ETF
Anteil0.1%
iShares U.S. Medical Devices ETF
Anteil0.07%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.03%
iShares Russell 2000 Growth ETF
Anteil0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.02%
iShares US Small-Cap Equity Factor ETF
Anteil0.02%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI